Neurogenesis as a New Target for the Development of Antidepressant Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|23|3763-3775

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.23, 2014-05, pp. : 3763-3775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link?

By  

Current Neuropharmacology, Vol. 11, Iss. 3, 2013-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs

By  

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1688-1698

Bentham Science Publishers

Access to resources Recommend Favorite

Increasing Hippocampal Neurogenesis: A Novel Mechanism for Antidepressant Drugs

By  

Current Pharmaceutical Design, Vol. 11, Iss. 2, 2005-01 ,pp. : 145-155

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Future Trends in the Development of New Antidepressant Drugs)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 23, 2014-05 ,pp. : 3717-3717

Bentham Science Publishers

Access to resources Recommend Favorite

Geminin as A Molecular Target for the Development of New Anticancer Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 461-462

Bentham Science Publishers

Access to resources Recommend Favorite